HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New CEO for International Flavors & Fragrances

This article was originally published in The Rose Sheet

Executive Summary

New York-based fragrance manufacturer announced Feb. 17 that current non-executive chairman Doug Tough will officially take helm as chairman and CEO March 1. Tough was appointed Sept. 14 following the resignation of chairman and CEO Robert Amen, but could not assume the new roles until his contract as CEO and managing director with health care protective barrier manufacturer Ansell Limited expired. The office of CEO at the firm has been staffed by CFO Kevin Berryman, Fragrances President Nicolas Mirzayantz and Flavors President Hernan Vaisman, all of whom have reported to Tough during the transition period. Tough, who has been on IFF's board since October 2008 and previously had a 17-year career in consumer products with Cadbury Schweppes, looks to "leverage the enormous opportunities that exist" for IFF

You may also be interested in...



Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line

The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.

Global Pharma Guidance Tracker – March 2024

Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.

EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials

Sponsors need guidance on ethics requirements and clarity around national regulations to conduct cross-border clinical trials in the EU, a multi-stakeholder forum says.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016747

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel